Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presurgical Proellex in Stage I-II Breast Cancer
NCT01800422Phase 2Unknown
- Sponsor
- Northwestern University
- Start
- Jun 2013
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in breast cancer, sponsored by Northwestern University. Status: unknown.
02
Drugs
telapristone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01800422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800422.